Market Closed

ELUT
Elutia
$ 0.8200
-6.69%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

Elutia News

Latest Elutia Stock News & ELUT Headlines

Elutia Inc. (ELUT) Q3 2026 Earnings Call Transcript
9 days ago | seekingalpha.com
Elutia Reports Third Quarter 2026 Results: As Plastic Surgeons Cite Infection Risk in Every Breast Research Session During National Meeting, NXT-41x Heads to FDA This Quarter, Fully Funded Through Launch
10 days ago | globenewswire.com
Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026
24 days ago | globenewswire.com
Financial Analysis: Elutia (NASDAQ:ELUT) & QuidelOrtho (NASDAQ:QDEL)
a month ago | defenseworld.net
Analyzing Elutia (NASDAQ:ELUT) and Edwards Lifesciences (NYSE:EW)
a month ago | defenseworld.net
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029
a month ago | globenewswire.com
Elutia to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15th
2 months ago | globenewswire.com
Elutia to Participate in the Lake Street Capital Markets 10th Annual Big Ideas Growth Conference & the H.C. Wainwright 28th Annual Global Investment Conference
2 months ago | globenewswire.com
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
3 months ago | globenewswire.com
Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
3 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

ELUT
Elutia
$ 0.8200
-6.69%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago